Mechanism and research progress of MAPK signaling pathway in myocardial fibrosis

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pathology

Background:

• Myocardial fibrosis (MF) is a significant pathological outcome in various cardiovascular diseases.
• MF is a critical component of cardiac remodeling processes.
• Specific signaling pathways, including p38 MAPK, JNK, and ERK, are implicated in the development of MF.

Purpose of the Study:

• To review the roles and intricate interactions of p38 MAPK, JNK, and ERK signaling pathways in myocardial fibrosis.
• To identify and summarize current and emerging drug and non-pharmacological therapies targeting these pathways for MF treatment.

Main Methods:

• Literature review of scientific publications.
• Analysis of signaling pathway mechanisms in cardiac remodeling.
• Synthesis of information on therapeutic interventions.

Main Results:

• Detailed explanation of how p38 MAPK, JNK, and ERK pathways contribute to MF.
• Identification of key molecular interactions within these pathways during fibrosis.
• Overview of pharmacological agents and lifestyle interventions targeting these pathways.

Conclusions:

• The p38 MAPK, JNK, and ERK pathways are crucial regulators of myocardial fibrosis.
• Targeting these signaling pathways presents a promising therapeutic strategy for cardiovascular diseases characterized by MF.
• Further research into combined and novel therapies is warranted.